Stevia

Zero-calorie, natural sweetener

Stevia is a widely approved natural sweetener derived from the leafy green plant Stevia rebaudiana. Stevia is rapidly gaining market traction because it is a natural, zero-calorie food and beverage sweetener that is suitable for the whole family including diabetics. Currently, only farm-derived Stevia is available. The Stevia plant is widely grown around the world today.

The Global sweetener market

The value of the global sweetener market (excluding sugar) is currently estimated at USD 4 billion. Within this market, Stevia-based sweeteners are the fastest-growing segment, with demand driven in part because Stevia extracts have 200-300 times the sweetness of sugar, but also because of increasing consumer demand for zero-calorie health, wellness and performance products. Extracts from Stevia’s sweet leaves are used as a zero-calorie sweetener in a wide variety of beverages including fruit juices and carbonated drinks, as well as in dairy products and tabletop sweeteners. In December 2011, the European Commission authorised the use of steviol glycosides in food and beverages. After the earlier clearance by regulators in the US and many other regions of the world, this marks a major breakthrough in the acceptance of Stevia as a sugar substitute.

Evolva’s Value Proposition

Like most things in nature, the science behind Stevia’s taste and potency is complex. The sweetness of the Stevia plant is due to the production of sweet constituents in its leaves. These constituents, also known as steviol glycosides, are up to 300 times the sweetness of sugar—without any calories. There are at least ten known steviol glycosides in the Stevia leaf with Stevioside and Rebaudioside A being the most prevalent.

Evolva has succeeded in making the key individual components of the sweetener Stevia via fermentation in yeast, using low-cost plant sugars as starting material. The availability of pure, fermentation-derived Stevia components has several key advantages for food and beverage manufacturers.

First, it bypasses the complex logistics associated with the traditional cultivation, processing and refining of Stevia plants. The end result is a new supply of Stevia that is more reliable and scalable, all at a lower cost — and this should give Evolva the ability to offer its Stevia product at a highly competitive price.

Secondly, it allows pure Stevia sweetness components to be produced. Several of the most attractive Stevia components are present at very low concentrations in the plant and are very hard to extract. Fermentation allows the production of the individual components in any required volume – making entirely new blends possible. This opens up the possibility for food and drinks manufacturers to fine-tune their products to local tastes.

Based on this set of advantages, pure fermentation-derived Stevia components could potentially accelerate adoption of Stevia and significantly expand the market for this sweetener.

Progress

In 2009, Evolva entered an agreement with Abunda regarding the discovery and development of food ingredients, with the agreement being expanded in 2010. One part of this collaboration was focused on producing the key constituents of stevia via fermentation in yeast. Numerous patent applications have been filed around the approach.

The programme has progressed well since inception. In July 2011, we made the strategic decision to acquire Abunda to gain full ownership of the firm’s Stevia and other nutritional ingredient programs. Stevia research is primarily conducted at Evolva’s Copenhagen site, with development activities in the USA.

Over the next year we will focus on moving the programme into pilot-scale. Based on current plans and expectations, our first Stevia product is expected to be available in 2015.

Contact Information

Evolva SA
Duggingerstrasse 23
CH-4153 Reinach
Switzerland
Tel: +41 61 485 2000
Fax: +41 61 485 2001
Evolva A/S
Lersoe Parkallé 42-44
DK-2100 Copenhagen OE
Denmark
Tel: +45 35 200 230
Fax: +45 35 200 231
Evolva Biotech Private Limited
401 - 405, 4th Floor
Ticel Bio Park Ltd
Taramani Road, Taramani
Chennai 600 113
Tamil Nadu, India
Tel: +91 44 4297 1050
Fax: +91 44 4297 1060
Evolva, Inc. (Evolva USA)
2440 Embarcadero Way
Palo Alto
CA 94303
USA
Tel: +1 650 856 2436
Fax: +1 650 856 7950

General Enquiries: info@evolva.com • Business Enquiries: busdev@evolva.com • India Enquiries: info_india@evolva.com